PTX

1:07 pm Pernix Therapeutics signs agreement with Osmotica Pharmaceuticals to promote KHEDEZLA (desvenlafaxine ER) for major depressive disorder

moreView todays social media effects on PTXView the latest stocks trending across Twitter. Click to view dashboardSee who Pernix is hiring next, click here to view […]

1:07 pm Pernix Therapeutics signs agreement with Osmotica Pharmaceuticals to promote KHEDEZLA (desvenlafaxine ER) for major depressive disorder

moreView todays social media effects on PTXView the latest stocks trending across Twitter. Click to view dashboardSee who Pernix is hiring next, click here to view […]

Pernix Signs Agreement with Osmotica Pharmaceutical Corp to Promote KHEDEZLA (Desvenlafaxine ER) Tablets, 50 mg and 100 mg for Major Depressive Disorder

[Business Wire] – Pernix Therapeutics Holdings, Inc. , a specialty pharmaceutical company, today announced that it has signed an agreement with Osmotica Pharmaceuticals Corp to market and sell KHEDEZLAâ„¢ Extended-Release Tablets, 50 mg and 100 mg. moreView todays social media effects on PTXView the latest stocks trending across Twitter. Click to view dashboardSee who Pernix is hiring next, click here […]

Pernix Signs Agreement with Osmotica Pharmaceutical Corp to Promote KHEDEZLA (Desvenlafaxine ER) Tablets, 50 mg and 100 mg for Major Depressive Disorder

[Business Wire] – Pernix Therapeutics Holdings, Inc. , a specialty pharmaceutical company, today announced that it has signed an agreement with Osmotica Pharmaceuticals Corp to market and sell KHEDEZLAâ„¢ Extended-Release Tablets, 50 mg and 100 mg. moreView todays social media effects on PTXView the latest stocks trending across Twitter. Click to view dashboardSee who Pernix is hiring next, click here […]

Pernix Signs Agreement with Osmotica Pharmaceutical Corp to Promote KHEDEZLA (Desvenlafaxine ER) Tablets, 50 mg and 100 mg for Major Depressive Disorder

[Business Wire] – Pernix Therapeutics Holdings, Inc. , a specialty pharmaceutical company, today announced that it has signed an agreement with Osmotica Pharmaceuticals Corp to market and sell KHEDEZLAâ„¢ Extended-Release Tablets, 50 mg and 100 mg. moreView todays social media effects on PTXView the latest stocks trending across Twitter. Click to view dashboardSee who Pernix is hiring next, click here […]

8:31 am Pernix Therapeutics closes $65 million institutional investment; amends Midcap revolver; moves to reshape Board of Directors

moreView todays social media effects on PTXView the latest stocks trending across Twitter. Click to view dashboardSee who Pernix is hiring next, click here to view […]

Pernix Closes $65 Million Institutional Investment; Amends MidCap Revolver; Moves to Reshape Board of Directors

[Business Wire] – Pernix Therapeutics Holdings, Inc. , a specialty pharmaceutical company, today announced that it has closed on the issuance of $65 milli moreView todays social media effects on PTXView the latest stocks trending across Twitter. Click to view dashboardSee who Pernix is hiring next, click here to view […]

Pernix Therapeutics to Present at the 25th Annual ROTH Growth Conference

[at noodls] – Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced that Cooper Collins, President and Chief Executive Officer, will present at the 25th Annual ROTH Growth … moreView todays social media effects on PTXView the latest stocks trending across Twitter. Click to view dashboardSee who Pernix is hiring next, click here to view […]

Pernix Therapeutics Completes Acquisition of Somaxon Pharmaceuticals, Inc.

[at noodls] – Pernix Therapeutics Holdings, Inc. (Pernix) (NASDAQ: PTX) today announced the completion of its acquisition of Somaxon Pharmaceuticals, Inc. (Somaxon) (NASDAQ: SOMX) following the … moreView todays social media effects on PTXView the latest stocks trending across Twitter. Click to view dashboardSee who Pernix is hiring next, click here to view […]